WaferGen Bio Management Performance Evaluation

WGBS -- USA Stock  

USD 6.90  0.00  0.00%

Analysis of WaferGen Bio manpower and management performance can provide insight into WaferGen Bio stock performance. Also an employee sentiment is becoming a valuable factor that investors can use to determine the amount of risk that may be associated with WaferGen Bio systems future performance. See also Your Current Watchlist.

WaferGen Bio Management Effectiveness

The company has return on total asset (ROA) of (90.11) % which means that it has lost $90.11 on every $100 spent on asset. This is way below average.

WaferGen Bio Workforce Comparison

WaferGen Bio systems is rated below average in number of employees category among related companies. The total workforce of Measuring and Control Equipment industry is at this time estimated at about 17,827. WaferGen Bio adds roughly 55.0 in number of employees claiming only tiny portion of all equities under Measuring and Control Equipment industry.

WaferGen Bio Profit Margins

The company has Profit Margin (PM) of (175.04) % which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (171.93) % which suggests for every $100 dollars of sales it generated a net operating loss of -1.72.

WaferGen Bio Insider Trading

WaferGen Bio Stakeholders

Rolland Carlson CEO and President and Director
Ivan Trifunovich Executive Chairman
Michael Henighan CFO, Secretary and Treasurer
Makoto Kaneshiro Independent Director
Robert Schueren Director
Joel Kanter Lead Independent Director
William McKenzie Director
Raymond Hautamaki Independent Director

WaferGen Bio Leadership

WaferGen Bio systems Top Executives

  Rolland Carlson  CEO
CEO and President and Director
  Ivan Trifunovich  Chairman
Executive Chairman

WaferGen Bio Tenure Analysis

WaferGen Bio Employment Tenure

WaferGen Bio employes about 55 people. The company is managed by 8 executives with total tenure of roughly 47 years, averanging almost 5.0 years of service per executive having 6.0 employee per reported executive.

WaferGen BioManpower Efficiency

Return on WaferGen Bio Manpower

Revenue Per Employee168 K
Revenue Per Executive1.2 M
Net Loss Per Employee379.1 K
Net Loss Per Executive2.6 M
Working Capital Per Employee70.9 K
Working Capital Per Executive487.6 K
See also Your Current Watchlist. Please also try Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Search macroaxis.com